These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6412725)

  • 1. [Autoradiographic studies on the protective effect of mesna in the urinary bladder mucosa of the rat during administration of cyclophosphamide (preliminary communication)].
    Kunze E; Köhnecke B; Engelhardt W; Brock N; Pohl J
    Arzneimittelforschung; 1983; 33(6):853-4. PubMed ID: 6412725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevention of cyclophosphamide-induced bladder swelling in the rat by I.V. administration of sodium-2-mercaptoethane sulfonate.
    Kedar A; Simpson CL; Williams P; Moore R; Tritsch G; Murphy GP
    Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):339-48. PubMed ID: 6774389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the uroprotector sodium 2-mercaptoethane sulfonate (Mesna) on the proliferation of the bladder urothelium in the rat after administration of cyclophosphamide.
    Kunze E; Köhnecke B; Engelhardt W; Steinröder H; Brock N; Pohl J
    Urol Int; 1984; 39(2):61-7. PubMed ID: 6426112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazaphosphorine cytostatics.
    Brock N; Pohl J
    IARC Sci Publ; 1986; (78):269-79. PubMed ID: 3108156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective role of thiols in cyclophosphamide-induced urotoxicity and depression of hepatic drug metabolism.
    Berrigan MJ; Marinello AJ; Pavelic Z; Williams CJ; Struck RF; Gurtoo HL
    Cancer Res; 1982 Sep; 42(9):3688-95. PubMed ID: 6809312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].
    Brock N; Stekar J
    Arzneimittelforschung; 1982; 32(5):486-7. PubMed ID: 6809014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of cyclophosphamide cystitis with 2-mercaptoethane sodium sulfonate: a histologic study.
    Freedman A; Ehrlich RM; Ljung BM
    J Urol; 1984 Sep; 132(3):580-2. PubMed ID: 6433044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of reduced glutathione with 2-mercaptoethane sulfonate to prevent cyclophosphamide-induced urotoxicity.
    Cavalletti E; Tofanetti O; Zunino F
    Cancer Lett; 1986 Jul; 32(1):1-6. PubMed ID: 3091245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of tumor formation in the bladder by sodium-2-mercaptoethane sulfonate (mesna). Experimental studies and clinical consequences].
    Schmähl D; Habs M; Tacchi AM
    Urologe A; 1984 Sep; 23(5):291-6. PubMed ID: 6438859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proliferation kinetics of regenerating urothelial cells in the rat urinary bladder after administration of cyclophosphamide (author's transl)].
    Kunze E; Engelhardt W; Steinröder H; Wöltjen HH; Schauer A
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1980; 33(1):47-66. PubMed ID: 6110265
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna).
    Brock N; Pohl J; Stekar J; Scheef W
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1377-87. PubMed ID: 6819957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds.
    Brock N; Pohl J; Stekar J
    J Cancer Res Clin Oncol; 1981; 100(3):311-20. PubMed ID: 6792207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of mesna for regional detoxification.
    Brock N; Pohl J
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():33-43. PubMed ID: 6414694
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of cyclophosphamide-induced carcinogenesis in the urinary bladder of rats by administration of mesna.
    Schmähl D; Habs MR
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():57-61. PubMed ID: 6414697
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2'-dithio-bis-ethane sulfonate (dimesna).
    Habs MR; Schmähl D
    Cancer; 1983 Feb; 51(4):606-9. PubMed ID: 6401591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of uroplakins by 2-mercaptoethanesulfonate in cyclophosphamide-induced rat cystitis.
    Kyung YS; Park HY; Lee G
    Arch Toxicol; 2011 Jan; 85(1):51-7. PubMed ID: 20186394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats.
    Ozcan A; Korkmaz A; Oter S; Coskun O
    Arch Toxicol; 2005 Aug; 79(8):461-5. PubMed ID: 15800758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetylcysteine and sodium 2-mercaptoethane sulfonate as sources of urinary thiol groups in the rat.
    Ormstad K; Ohno Y
    Cancer Res; 1984 Sep; 44(9):3797-800. PubMed ID: 6430554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro/in vivo effects of Mesna on the genotoxicity and toxicity of cyclophosphamide--a study aimed at clarifying the mechanism of Mesna's anticarcinogenic activity.
    Pool BL; Bos RP; Niemeyer U; Theuws JL; Schmähl D
    Toxicol Lett; 1988 Apr; 41(1):49-56. PubMed ID: 3128896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protecting the bladder from cyclophosphamide with mesna.
    Finn GP; Sidau B; Shaw IC
    N Engl J Med; 1986 Jan; 314(1):61. PubMed ID: 3079620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.